NEW YORK, NY. March 6, 2019. Depleting the number of harmful B cells with a novel immunotherapy that employs modified T cells may offer an effective strategy to treat lupus, according to a new study funded by the Lupus Research Alliance. These findings offer a renewed optimism for the elimination of B cells to provide […] READ MORE
New York, NY– March 1. The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration with Takeda Pharmaceutical Company Limited, to evaluate the investigational biologic TAK-079 as a potential new therapy for lupus in a Phase 1 trial (NCT03724916). The national study will be conducted in 20 research centers throughout the country, many […] READ MORE
February 28, 2019 NEW YORK, NY. As a co-sponsor of the National Institutes of Health (NIH) public-private Accelerating Medicines Partnership (AMP), the Lupus Research Alliance is proud to share the project’s five-year achievements reported in Nature Reviews Drug Discovery. In the article, NIH Director Dr. Francis Collins points to new technology standards AMP created for […] READ MORE
NEW YORK, NY. February 19. Pieces of bacteria that escape from the intestines may trigger lupus and associated disease flares in some patients, according to a new study partly funded by the Lupus Research Alliance. These findings may allow disease treatment with probiotics or diets that alter the mix of bacterial species in the intestines. […] READ MORE
February 1, 2019 Today, Lupus Therapeutics, an affiliate of Lupus Research Alliance, is launching our Patient Advocates for Lupus Studies (PALS) program with a pilot study to determine its effectiveness in increasing awareness of and participation in lupus clinical trials, particularly among diverse populations. The program will pair people with lupus interested in learning about […] READ MORE
February 1, 2019 The Lupus Research Alliance announced that its affiliate Lupus Therapeutics is working with the pharmaceutical company, Janssen, to help conduct a Phase 3 trial to evaluate whether their drug ustekinumab (Stelara®) may offer benefit to people with lupus. Called LOTUS, the international study is being conducted in over 200 sites, 20 of […] READ MORE
NEW YORK, NY – January 10. Can “borrowed” drugs for treating other diseases protect the skin in patients with lupus? Can researchers coax the body to weed out harmful immune cells that drive tissue destruction in lupus? Those are just two of the innovative approaches for lupus therapies recognized by the Lupus Research Alliance with […] READ MORE
NEW YORK, NY. December 20. The Board of Directors and staff of the Lupus Research Alliance mourn the death of Stephen Katz, MD, PhD, a true champion for the lupus community. For over two decades, Dr. Katz has served as Director of the home institute for lupus at the National Institutes of Health (NIH), the […] READ MORE
NEW YORK, NY. December 20. The Lupus Research Alliance is proud to announce the 2018 recipients of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Nir Hacohen, PhD (right) and Vijay Kuchroo, DVM, PhD (left). Dr. Hacohen is seeking better ways to treat lupus kidney disease, the major cause of illness and […] READ MORE
The Lupus Research Alliance 2018 Breaking Through Gala honored Board member William J. Wolfe, Chairman and CEO of First Washington Realty, Inc. for his instrumental role in uniting the lupus community to an unparalleled global research enterprise. With the generous support of 650 attendees, the evening raised over $3.5 million specifically for lupus research. Mr. […] READ MORE
2018 Awards Enable Promising Scientists to Bring Innovative Approaches to Lupus Research October 18, 2018 The Lupus Research Alliance announced six new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants support researchers who study lupus from many perspectives, testing new theories about what causes lupus and […] READ MORE
NEW YORK, NY. Sept. 28 – Congratulations go out to the Lupus Research Alliance advocates! The 2019 spending bill was signed into law today, granting the two requests Lupus Research Alliance advocates made to legislators on “Capitol Hill Day” in March 2018. Approved by Congress earlier in the week, the bill provides $5 million for […] READ MORE